alexa
Reach Us +3225889658
Method Validation for Stability Indicating Method of Related Substance in Active Pharmaceutical Ingredients Dabigatran Etexilate Mesylate by Reverse Phase Chromatography | Abstract
ISSN: 2157-7064

Journal of Chromatography & Separation Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article

Method Validation for Stability Indicating Method of Related Substance in Active Pharmaceutical Ingredients Dabigatran Etexilate Mesylate by Reverse Phase Chromatography

Dare M1, Jain R2* and Pandey A2

1Department of Analytical development API Micro Labs Limited-API Banglore 560001, India

2Department of chemistry, Dr. Hari Singh Gour University, Sagar, India,

*Corresponding Author:
Jain R
Department of chemistry
Dr. Hari Singh Gour University, Sagar, India
Tel: +919008777114, 0016786069025
E-mail: [email protected]

Received date: December 09, 2014; Accepted date: January 16, 2015; Published date: January 22, 2015

Citation: Dare M, Jain R, Pandey A (2015) Method Validation for Stability Indicating Method of Related Substance in Active Pharmaceutical Ingredients Dabigatran Etexilate Mesylate by Reverse Phase Chromatography. J Chromatogr Sep Tech 6:263. doi:10.4172/2157-7064.1000263

Copyright: © 2015 Dare M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

To develop the stability indicating, highly accurate precise and linear method for related substance of the Dabigatran through the reverse phase high performance liquid chromatography and it is validated as per the current ICH guideline. The optimize method uses a reverse phase column, Poroshell 120 EC -18 (150 mm × 4.6 mm, 2.7μ), Mobile Phase of hexane-1 Sulfonic acid sodium salt monohydrate (6.5 ± 0.05) and Methanol through gradient flow rate of 0.6ml/min. Keeping the column at temperature 30°C and using the sample amount 10 μL at 5°C and detected all the impurities at 230 nm by the UV detector. In the developed method, elution of Dabigatran was at 26.9 min and all the eluted Impurities were well separated and met the system suitability criteria. The precision is exemplified by relative standard deviation of 0.40%. Method percentage mean recoveries of all the impurities are within the range (90.0% to 115.0%) as per the protocol. Resolution results show that the method is robust. Linearity coefficient for all Impurities is more than 0.999. The LOD obtained is 0.01% and LOQ is 0.03%. A new highly accurate, precise and stability indicating method was developed for related substance of Dabigatran with all the impurities well separate from the degradation product of Dabigatran. It is ready to use for the routine analysis of related substance of Dabigatran in Pharmaceutical industry.

Keywords

Top